Guardian Wealth Advisors (North Carolina)’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,751
Closed -$218K 617
2025
Q4
$218K Buy
2,751
+11
+0.4% +$867 0.01% 348
2025
Q3
$207K Buy
+2,740
New +$188K 0.01% 343
2024
Q2
Sell
-5,203
Closed -$415K 440
2024
Q1
$415K Buy
5,203
+256
+5% +$19.6K 0.05% 179
2023
Q4
$391K Sell
4,947
-451
-8% -$32.1K 0.06% 165
2023
Q3
$377K Sell
5,398
-628
-10% -$44.5K 0.06% 153
2023
Q2
$417K Buy
6,026
+2
+0% +$142 0.07% 143
2023
Q1
$448K Buy
6,024
+828
+16% +$69.4K 0.08% 130
2022
Q4
$484K Buy
5,196
+139
+3% +$13.4K 0.09% 115
2022
Q3
$482K Buy
5,057
+1,353
+37% +$134K 0.09% 106
2022
Q2
$343K Buy
3,704
+633
+21% +$61.8K 0.06% 132
2022
Q1
$311K Buy
+3,071
New +$323K 0.13% 117

Other funds holding CVS

Guardian Wealth Advisors (North Carolina)'s CVS Position: Q1 2026 in Review

Guardian Wealth Advisors (North Carolina) sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,751 shares — an estimated $218K sold.

Guardian Wealth Advisors (North Carolina) first reported a position in CVS in Q1 2022 and held it in 11 quarters. The position peaked at $484K in Q4 2022. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Guardian Wealth Advisors (North Carolina) reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Guardian Wealth Advisors (North Carolina) sold 2,751 CVS Health shares in Q1 2026, an estimated $218K.
  • Guardian Wealth Advisors (North Carolina) first reported a position in CVS Health in Q1 2022 and held it in 11 quarters.
  • Guardian Wealth Advisors (North Carolina)'s CVS Health position peaked at $484K in Q4 2022.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.